Please login to the form below

Not currently logged in
From: Sales

Pfizer set to file Xeljanz for psoriasis

Pfizer headquartersSet to add another indication after positive study results

From: Sales

Pfizer rumoured to be after AstraZeneca

Pfizer AstraZenecaIs this the return of the pharma mega-merger?

From: Sales

NICE backs two cancer drugs

National Institute for Health and Care Excellence NICE logoBoehringer’s Giotrif and Janssen’s Velcade given final go-ahead for NHS use

From: Sales

Novartis pays $16bn for GSK's oncology portfolio

Novartis buildingSwiss company strikes series of deals, including one to step away from vaccines

Sex is a good trick

But pharma companies - and payers - should stop incestuous ‘best practice’ behaviours and look for new ways of comparing options

Tuberculosis: treatment and prevention

One of the most significant global diseases, effective new TB therapies are sorely needed

Number of HCPs on Twitter tops 75,000

Doctors, nurses, pharmacists and consultants posting more than 152,000 tweets a day

Doctors HCPs Twitter

Merck Serono CEO joins L’Oreal board

Belén Garijo named independent director at beauty company

Merck Serono Belen Garijo

Integrating multichannel marketing

External forces are driving the need for pharma to use a greater variety of channels to reach customers

Spectrum appoints Dr Dalna Harvey as regulatory project manager

She brings experience gained at firms such as Parexel, Chiron and Wyeth


The new hepatitis C treatment landscape

Free Atlantis Healthcare Webinar

European Commission launches mHealth consultation

May lead to policy action by 2015

Mobile device

Featured jobs

Subscribe to our email news alerts


Add my company

At Pegasus, we specialise in helping deliver healthy messages through integrated communication programmes. In fact, inspiring healthy decisions is all...

Latest intelligence

Online Physician Communities
Study highlights value of internet for doctors in Eastern Europe
Electronic direct mail is proving popular as online access increases...
England’s clinical commissioning landscape
Who are the real masters in the new NHS?...
How will the new landscape of Hep C treatments affect patients?
The development of new therapeutic agents is set to transform the treatment of hepatitis C over the coming years....